tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

SUPN Stock Latest News

Piper upgrades Supernus on ‘promising’ Onapgo trajectory
The FlyPiper upgrades Supernus on ‘promising’ Onapgo trajectory
1d ago
SUPN
Supernus upgraded to Overweight from Neutral at Piper Sandler
PremiumThe Fly
Supernus upgraded to Overweight from Neutral at Piper Sandler
2d ago
SUPN
Supernus price target raised to $63 from $46 at Cantor Fitzgerald
PremiumThe Fly
Supernus price target raised to $63 from $46 at Cantor Fitzgerald
10d ago
SUPN
Supernus price target raised to $40 from $36 at Piper Sandler
PremiumThe Fly
Supernus price target raised to $40 from $36 at Piper Sandler
1M ago
SUPN
Supernus Pharmaceuticals’ Earnings Call Highlights Growth Amid Challenges
PremiumCompany Announcements
Supernus Pharmaceuticals’ Earnings Call Highlights Growth Amid Challenges
2M ago
SUPN
Supernus Pharmaceuticals Reports Strong Q2 2025 Results
PremiumCompany AnnouncementsSupernus Pharmaceuticals Reports Strong Q2 2025 Results
2M ago
SUPN
Supernus reports Q2 EPS 40c vs. 36c last year
Premium
The Fly
Supernus reports Q2 EPS 40c vs. 36c last year
2M ago
SUPN
Supernus raises FY25 revenue view $670M-$700M from $600M-$630M
Premium
The Fly
Supernus raises FY25 revenue view $670M-$700M from $600M-$630M
2M ago
SUPN
Supernus Pharmaceuticals (SUPN) Q2 Earnings Cheat Sheet
PremiumPre-Earnings
Supernus Pharmaceuticals (SUPN) Q2 Earnings Cheat Sheet
2M ago
SUPN
Supernus Pharmaceuticals Completes Acquisition of Sage Therapeutics
PremiumCompany Announcements
Supernus Pharmaceuticals Completes Acquisition of Sage Therapeutics
2M ago
8K
SUPN
Supernus completes acquisition of Sage Therapeutics
PremiumThe Fly
Supernus completes acquisition of Sage Therapeutics
2M ago
SAGE
SUPN
Cantor upgrades Supernus on outlook for ADHD treatment
PremiumThe Fly
Cantor upgrades Supernus on outlook for ADHD treatment
2M ago
SUPN
Supernus upgraded to Overweight from Neutral at Cantor Fitzgerald
PremiumThe FlySupernus upgraded to Overweight from Neutral at Cantor Fitzgerald
2M ago
SUPN
Supernus announces expiration of HSR waiting period for Sage Therapeutics
Premium
The Fly
Supernus announces expiration of HSR waiting period for Sage Therapeutics
2M ago
SAGE
SUPN
Sage Therapeutics cutting over 330 jobs, Boston Globe reports
Premium
The Fly
Sage Therapeutics cutting over 330 jobs, Boston Globe reports
3M ago
SAGE
SUPN
Supernus Pharmaceuticals Holds Annual Stockholders Meeting
PremiumCompany Announcements
Supernus Pharmaceuticals Holds Annual Stockholders Meeting
4M ago
8K
SUPN
H.C. Wainwright sees potential competition for Sage from Biogen
PremiumThe Fly
H.C. Wainwright sees potential competition for Sage from Biogen
4M ago
BIIB
SAGE
Sage Therapeutics price target raised to $9 from $8 at Truist
PremiumThe Fly
Sage Therapeutics price target raised to $9 from $8 at Truist
4M ago
SAGE
SUPN
Sage Therapeutics price target raised to $8.50 from $8 at Canaccord
PremiumThe Fly
Sage Therapeutics price target raised to $8.50 from $8 at Canaccord
4M ago
BIIB
SAGE
Sage Therapeutics price target raised to $8.50 from $8 at Canaccord
PremiumThe FlySage Therapeutics price target raised to $8.50 from $8 at Canaccord
4M ago
BIIB
SAGE
Sarepta suspends Elevidys shipments, Supernus acquires Sage: Morning Buzz
Premium
The Fly
Sarepta suspends Elevidys shipments, Supernus acquires Sage: Morning Buzz
4M ago
BA
BMY
Morning Movers: Sage Therapeutics surges after deal to be acquired by Supernus
Premium
The Fly
Morning Movers: Sage Therapeutics surges after deal to be acquired by Supernus
4M ago
X
AMZN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >